| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.33 | 9e-21 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.31 | 1e-18 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.29 | 5e-16 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.28 | 6e-16 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.26 | 4e-15 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.27 | 5e-14 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.26 | 3e-13 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-12 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.35 | 2e-11 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-10 |